Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 272

Similar articles for PubMed (Select 19095663)

1.

An RCT of metformin versus orlistat for the management of obese anovulatory women.

Metwally M, Amer S, Li TC, Ledger WL.

Hum Reprod. 2009 Apr;24(4):966-75. doi: 10.1093/humrep/den454. Epub 2008 Dec 18.

2.

The effects of metformin or orlistat on obese women with polycystic ovary syndrome: a prospective randomized open-label study.

Ghandi S, Aflatoonian A, Tabibnejad N, Moghaddam MH.

J Assist Reprod Genet. 2011 Jul;28(7):591-6. doi: 10.1007/s10815-011-9564-2. Epub 2011 Apr 12.

3.

Evaluation of the safety and efficacy of sibutramine, orlistat and metformin in the treatment of obesity.

Gokcel A, Gumurdulu Y, Karakose H, Melek Ertorer E, Tanaci N, BascilTutuncu N, Guvener N.

Diabetes Obes Metab. 2002 Jan;4(1):49-55.

PMID:
11874442
4.
5.

Efficacy predictors for metformin and clomiphene citrate treatment in anovulatory infertile patients with polycystic ovary syndrome.

Palomba S, Falbo A, Orio F Jr, Tolino A, Zullo F.

Fertil Steril. 2009 Jun;91(6):2557-67. doi: 10.1016/j.fertnstert.2008.03.011. Epub 2008 Apr 28.

PMID:
18440534
6.

Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.

Panidis D, Farmakiotis D, Rousso D, Kourtis A, Katsikis I, Krassas G.

Fertil Steril. 2008 Apr;89(4):899-906. Epub 2007 Nov 5.

PMID:
17980364
7.

X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance.

Toplak H, Ziegler O, Keller U, Hamann A, Godin C, Wittert G, Zanella MT, Zúñiga-Guajardo S, Van Gaal L.

Diabetes Obes Metab. 2005 Nov;7(6):699-708.

PMID:
16219013
8.

Effect of metformin, orlistat and pioglitazone treatment on mean insulin resistance and its biological variability in polycystic ovary syndrome.

Cho LW, Kilpatrick ES, Keevil BG, Coady AM, Atkin SL.

Clin Endocrinol (Oxf). 2009 Feb;70(2):233-7. doi: 10.1111/j.1365-2265.2008.03309.x. Epub 2008 Jun 10.

PMID:
18547343
9.

The effects of orlistat in patients with diabetes: improvement in glycaemic control and weight loss.

Rowe R, Cowx M, Poole C, McEwan P, Morgan C, Walker M.

Curr Med Res Opin. 2005 Nov;21(11):1885-90.

PMID:
16307710
10.

Endocrine consequences of weight loss in obese, hyperandrogenic, anovulatory women.

Guzick DS, Wing R, Smith D, Berga SL, Winters SJ.

Fertil Steril. 1994 Apr;61(4):598-604.

PMID:
8150098
11.

Does metformin induce ovulation in normoandrogenic anovulatory women?

Carmina E, Lobo RA.

Am J Obstet Gynecol. 2004 Nov;191(5):1580-4.

PMID:
15547527
12.

[Effects of metformin on hyperinsulinemic anovulation].

Li R, Lin J, Zhou J.

Zhonghua Fu Chan Ke Za Zhi. 2001 May;36(5):296-8. Chinese.

PMID:
11783382
13.

Sensitization to insulin induces ovulation in nonobese adolescents with anovulatory hyperandrogenism.

Ibáñez L, Valls C, Ferrer A, Marcos MV, Rodriguez-Hierro F, de Zegher F.

J Clin Endocrinol Metab. 2001 Aug;86(8):3595-8.

PMID:
11502783
14.
15.

NPY5R antagonism does not augment the weight loss efficacy of orlistat or sibutramine.

Erondu N, Addy C, Lu K, Mallick M, Musser B, Gantz I, Proietto J, Astrup A, Toubro S, Rissannen AM, Tonstad S, Haynes WG, Gottesdiener KM, Kaufman KD, Amatruda JM, Heymsfield SB.

Obesity (Silver Spring). 2007 Aug;15(8):2027-42.

PMID:
17712121
16.

Disparate effects of pharmacotherapy on plasma plasminogen activator inhibitor-1 levels in women with the polycystic ovary syndrome.

Koiou E, Tziomalos K, Katsikis I, Delkos D, Tsourdi EA, Panidis D.

Hormones (Athens). 2013 Oct-Dec;12(4):559-66.

17.

Metformin versus sibutramine in the treatment of hyperinsulinemia in chronically anovulating women.

Lazurova I, Dravecka I, Kraus V, Petrovicova J.

Bratisl Lek Listy. 2004;105(5-6):207-10.

PMID:
15535111
18.

Insulin sensitizing drugs for weight loss in women of reproductive age who are overweight or obese: systematic review and meta-analysis.

Nieuwenhuis-Ruifrok AE, Kuchenbecker WK, Hoek A, Middleton P, Norman RJ.

Hum Reprod Update. 2009 Jan-Feb;15(1):57-68. doi: 10.1093/humupd/dmn043. Epub 2008 Oct 15. Review.

19.

The effects of 8 months of metformin on circulating GGT and ALT levels in obese women with polycystic ovarian syndrome.

Preiss D, Sattar N, Harborne L, Norman J, Fleming R.

Int J Clin Pract. 2008 Sep;62(9):1337-43. doi: 10.1111/j.1742-1241.2008.01825.x. Epub 2008 Jun 28.

PMID:
18565127
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk